Clinical Trial Update: Study of a Nebulised Nitric Oxide Generating Solution in Patients With Mycobacterium Abscessus [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a nebulised nitric oxide generating solution in cystic fibrosis patients with Mycobacterium abscessus has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Nebulised nitric oxide generating solution

Snippet

Sponsor: Papworth Hospital NHS Foundation Trust | Conditions: Cystic Fibrosis | Phase 2 | Status: TERMINATED